Skip to content

Role of VI-RADS scoring in predicting tumor pathology

VI-RADS/Likert performance and clinical implications on decision making in Tumor Pathological Study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/05/042668
Enrollment
50
Registered
2022-05-19
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C67- Malignant neoplasm of bladder

Interventions

None listed

Sponsors

KMC Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the patients admitted in Urology department of Kasturba Hospital, Manipal with bladder mass on either any radiological investigation (ultrasonography, MRI) or diagnosed by cystoscopy (done anywhere else and referred to us without TURBT) and diagnosed with bladder cancer

Exclusion criteria

Exclusion criteria: 1. Patients with metastasis 2. Patients with previous history of surgery, chemotherapy or radiotherapy for bladder tumor (primary bladder tumor or any pelvic tumor infiltrating bladder). 3. Patients in whom MRI was contraindicated/lack of consent. 4. Patients having non-transitional cell carcinoma (TCC) cancer, variant histology or carcinoma in situ (CIS) on HPE.

Design outcomes

Primary

MeasureTime frame
To evaluate and compare accuracy of VIRADS scoring for staging of bladder carcinoma preoperatively in comparison with postoperative histological grade.Timepoint: 4 weeks

Secondary

MeasureTime frame
1. To verify the accuracy of the VI-RADS scoring system in predicting muscle-invasive bladder cancer and to explore its value in clinical application and management. 2. To know the diagnostic performance of Vesical Imaging-Reporting and Data System (VIRADS) and to find a quantitative indicator for predicting muscle invasion of bladder cancer. 3. To correlate bi-parametric scoring with conventional VIRADS in diagnostic accuracy.Timepoint: 4 weeks

Countries

India

Contacts

Public ContactDr Arun Chawla

KMC Manipal

urologyarun@yahoo.com9008002440

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026